|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the dispensing of aesthetic pharmaceuticals by |
|
physicians and therapeutic optometrists; imposing fees. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subtitle A, Title 3, Occupations Code, is |
|
amended by adding Chapter 116 to read as follows: |
|
CHAPTER 116. DISPENSING OF AESTHETIC PHARMACEUTICALS |
|
Sec. 116.001. DEFINITIONS. In this chapter: |
|
(1) "Aesthetic pharmaceutical" means: |
|
(A) a drug listed in the aesthetic pharmaceutical |
|
group under Section 116.005; or |
|
(B) a drug that: |
|
(i) is not a controlled substance; |
|
(ii) requires a prescription for |
|
dispensation; |
|
(iii) is legally marketed under 21 U.S.C. |
|
Section 355, if it is a new drug subject to that section; and |
|
(iv) is prescribed for the enhancement of |
|
an individual's appearance. |
|
(2) "Physician" means a person licensed to practice |
|
medicine under Subtitle B. |
|
(3) "Therapeutic optometrist" means a person licensed |
|
to practice therapeutic optometry under Chapter 351. |
|
Sec. 116.002. DISPENSING PERMITTED; FEE AUTHORIZED. (a) A |
|
physician or therapeutic optometrist may dispense to the |
|
physician's or therapeutic optometrist's patients an aesthetic |
|
pharmaceutical in excess of the patient's immediate needs without |
|
obtaining a license under Chapter 558. The physician or |
|
therapeutic optometrist may charge a fee for dispensing the |
|
pharmaceutical. |
|
(b) A therapeutic optometrist may not dispense an aesthetic |
|
pharmaceutical if that prescription does not fall within the scope |
|
of the practice of therapeutic optometry, as defined by Section |
|
351.002. |
|
Sec. 116.003. NOTICE; LABELING; RECORDKEEPING. |
|
(a) Before dispensing an aesthetic pharmaceutical to a patient, a |
|
physician or therapeutic optometrist must inform the patient that |
|
the prescription for the pharmaceutical may be filled at a |
|
pharmacy, if available at a pharmacy, or dispensed in the |
|
physician's or therapeutic optometrist's office. |
|
(b) Each state and federal labeling and recordkeeping |
|
requirement applicable to an aesthetic pharmaceutical must be |
|
followed and documented. A record maintained under this section |
|
must be accessible as provided under state and federal law. |
|
Sec. 116.004. RULES; FEES. The Texas Medical Board shall |
|
adopt rules for physicians and the Texas Optometry Board shall |
|
adopt rules for therapeutic optometrists to govern the packaging, |
|
labeling, and dispensing of aesthetic pharmaceuticals under this |
|
chapter. The Texas Medical Board and the Texas Optometry Board |
|
shall adopt reasonable fees as necessary to implement this chapter. |
|
A fee adopted under this section may not exceed a fee adopted under |
|
Section 554.006 for authorizing a pharmacist to dispense |
|
pharmaceuticals. |
|
Sec. 116.005. AESTHETIC PHARMACEUTICAL GROUP. The |
|
aesthetic pharmaceutical group consists of: |
|
(1) bimatoprost; |
|
(2) hydroquinone; |
|
(3) tretinoin; |
|
(4) metronidazole; |
|
(5) tazarotene; |
|
(6) eflornithine; |
|
(7) dapsone; |
|
(8) salicylic acid; |
|
(9) urea topicals; |
|
(10) mequinol; and |
|
(11) resorcinol. |
|
SECTION 2. Section 157.002(f), Occupations Code, is amended |
|
to read as follows: |
|
(f) Subsections (b) and (c) do not authorize a physician or |
|
a person acting under the supervision of a physician to keep a |
|
pharmacy, advertised or otherwise, for the retail sale of dangerous |
|
drugs, other than as authorized under Chapter 116 and Section |
|
158.003, without complying with the applicable laws relating to the |
|
dangerous drugs. |
|
SECTION 3. Section 563.051(d), Occupations Code, is amended |
|
to read as follows: |
|
(d) This section does not authorize a physician or a person |
|
acting under the supervision of a physician to keep a pharmacy, |
|
advertised or otherwise, for the retail sale of dangerous drugs, |
|
other than as authorized under Chapter 116 and Section 158.003, |
|
without complying with the applicable laws relating to the |
|
dangerous drugs. |
|
SECTION 4. The Texas Medical Board and the Texas Optometry |
|
Board shall adopt rules for the implementation of Chapter 116, |
|
Occupations Code, as added by this Act, not later than March 1, |
|
2016. |
|
SECTION 5. (a) Except as provided by Subsection (b) of |
|
this section, this Act takes effect immediately if it receives a |
|
vote of two-thirds of all the members elected to each house, as |
|
provided by Section 39, Article III, Texas Constitution. If this |
|
Act does not receive the vote necessary for immediate effect, this |
|
Act takes effect September 1, 2015. |
|
(b) Sections 116.002 and 116.003, Occupations Code, as |
|
added by this Act, take effect March 1, 2016. |